• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清SIRT 2升高可能有助于鉴别帕金森病与非典型帕金森综合征。

Elevated Serum SIRT 2 May Differentiate Parkinson's Disease From Atypical Parkinsonian Syndromes.

作者信息

Singh Amrendra Pratap, Ramana G, Bajaj Teena, Singh Vishwajeet, Dwivedi Sadanand, Behari Madhuri, Dey A B, Dey Sharmistha

机构信息

Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.

Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Front Mol Neurosci. 2019 Jun 12;12:129. doi: 10.3389/fnmol.2019.00129. eCollection 2019.

DOI:10.3389/fnmol.2019.00129
PMID:31244600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6581755/
Abstract

Atypical Parkinson syndromes (APSs) often have symptoms that overlap with those of Parkinson's disease (PD), especially early in the disease, making these disorders difficult to diagnose. Previous studies have demonstrated an association of oligomeric α-synuclein (α-Syn), a key element in the pathogenesis of PD, with Sirtuin (SIRT)2 proteins for modulating PD. We aimed to evaluate SIRT protein expression in serum of PD patients and compare it with APSs and normal elderly control (GC) and to correlate this with α-Syn. SIRT protein expression was evaluated in sera of 68 PD; 34 APS and 68 GC without any neuro-psychiatric illness as controls by surface plasmon resonance (SPR). SIRT2 expression was correlated with α-Syn in PD and GC. Significant ( < 0.0001) differences were observed between serum SIRT2 concentration in PD and APS and GC as well as between APS and GC. Receiver operating characteristic (ROC) analysis revealed the strong cut-off value to differentiate PD from APS and GC and also APS from GC. Significant correlation was observed among SIRT2 levels in early PD patients with Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn & Yahr (H & Y) and increased duration of disease. In addition, a strong positive correlation of SIRT2 with α-Syn ( < 0.0001) was observed. However, no such difference was detected for serum SIRT1 in cases of PD and APS or for GC. The present study is the first to report elevated serum SIRT2 in PD. The study also provided a simple test to distinguish PD from APS and may have translational utility for diagnosis.

摘要

非典型帕金森综合征(APSs)的症状常与帕金森病(PD)重叠,尤其是在疾病早期,这使得这些疾病难以诊断。先前的研究已证明,寡聚α-突触核蛋白(α-Syn)是PD发病机制中的关键要素,与沉默调节蛋白(SIRT)2蛋白在调节PD方面存在关联。我们旨在评估PD患者血清中的SIRT蛋白表达,并将其与APSs患者及正常老年对照(GC)进行比较,同时将其与α-Syn进行关联分析。通过表面等离子体共振(SPR)技术,对68例PD患者、34例APS患者以及68例无任何神经精神疾病的GC患者血清中的SIRT蛋白表达进行了评估。在PD患者和GC患者中,对SIRT2表达与α-Syn进行了相关性分析。结果发现,PD患者与APS患者及GC患者血清中SIRT2浓度之间存在显著差异(<0.0001),APS患者与GC患者之间也存在显著差异。受试者工作特征(ROC)分析显示,有较强的临界值可用于区分PD与APS及GC,以及区分APS与GC。早期PD患者的SIRT2水平与统一帕金森病评定量表(UPDRS)、霍恩和亚尔分级(H&Y)以及病程延长之间存在显著相关性。此外,还观察到SIRT2与α-Syn之间存在强正相关(<0.0001)。然而,在PD和APS患者或GC患者中,未检测到血清SIRT1有此类差异。本研究首次报道了PD患者血清中SIRT2升高。该研究还提供了一种简单的检测方法来区分PD与APS,可能具有诊断方面的转化应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/bb34d1c2cef4/fnmol-12-00129-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/eee8e8b84499/fnmol-12-00129-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/1bdf7f4881ef/fnmol-12-00129-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/bb34d1c2cef4/fnmol-12-00129-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/eee8e8b84499/fnmol-12-00129-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/1bdf7f4881ef/fnmol-12-00129-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a378/6581755/bb34d1c2cef4/fnmol-12-00129-g0003.jpg

相似文献

1
Elevated Serum SIRT 2 May Differentiate Parkinson's Disease From Atypical Parkinsonian Syndromes.血清SIRT 2升高可能有助于鉴别帕金森病与非典型帕金森综合征。
Front Mol Neurosci. 2019 Jun 12;12:129. doi: 10.3389/fnmol.2019.00129. eCollection 2019.
2
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.寡聚 α-突触核蛋白和 tau 聚集物在 NDEVs 中区分帕金森病与非典型帕金森病。
Neurobiol Dis. 2023 Jan;176:105947. doi: 10.1016/j.nbd.2022.105947. Epub 2022 Dec 5.
3
Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.血浆生物标志物可区分帕金森病与非典型帕金森综合征。
Front Aging Neurosci. 2018 Apr 27;10:123. doi: 10.3389/fnagi.2018.00123. eCollection 2018.
4
Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.帕金森病中小唾液腺活检中硝化的α-突触核蛋白。
Neurosci Lett. 2019 Jun 21;704:45-49. doi: 10.1016/j.neulet.2019.03.054. Epub 2019 Apr 1.
5
Serum Mortalin Correlated with α-Synuclein as Serum Markers in Parkinson's Disease: A Pilot Study.血清 Mortalin 与 α-突触核蛋白相关,可作为帕金森病的血清标志物:一项初步研究。
Neuromolecular Med. 2018 Mar;20(1):83-89. doi: 10.1007/s12017-017-8475-5. Epub 2018 Jan 6.
6
Reduced serum SIRT1 levels in patients with Parkinson's disease: a cross-sectional study in China.帕金森病患者血清SIRT1水平降低:一项中国的横断面研究
Neurol Sci. 2021 May;42(5):1835-1841. doi: 10.1007/s10072-020-04711-z. Epub 2020 Sep 9.
7
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease.血浆和血清α-突触核蛋白作为帕金森病患者诊断的生物标志物
Front Neurol. 2020 Jan 21;10:1388. doi: 10.3389/fneur.2019.01388. eCollection 2019.
8
Neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to differentiate Parkinson's disease from atypical parkinsonian syndromes.神经退行性变、氧化应激和脂代谢的血浆生物标志物可用于区分帕金森病和非典型帕金森综合征。
Rev Neurol (Paris). 2023 Nov;179(9):961-966. doi: 10.1016/j.neurol.2022.12.015. Epub 2023 Jun 14.
9
Oral Mucosa Derived α-Synuclein as a Potential Diagnostic Biomarker for Parkinson's Disease.口腔黏膜来源的α-突触核蛋白作为帕金森病的潜在诊断生物标志物
Front Aging Neurosci. 2022 Mar 28;14:867528. doi: 10.3389/fnagi.2022.867528. eCollection 2022.
10
Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT.使用DaTSCAN®单光子发射计算机断层扫描对帕金森病和非典型帕金森综合征患者多巴胺能变性模式的视觉评估与半定量比率计算之间的比较。
Ann Nucl Med. 2014 Nov;28(9):851-9. doi: 10.1007/s12149-014-0878-x. Epub 2014 Jul 6.

引用本文的文献

1
Fluid biomarkers in atypical Parkinsonism: current state and future perspectives.非典型帕金森病中的体液生物标志物:现状与未来展望
J Neural Transm (Vienna). 2025 May 20. doi: 10.1007/s00702-025-02930-2.
2
Elevated SIRT2 of serum exosomes is positively correlated with diagnosis of acute ischemic stroke patients.血清外泌体中 SIRT2 的升高与急性缺血性脑卒中患者的诊断呈正相关。
BMC Neurol. 2023 Sep 8;23(1):321. doi: 10.1186/s12883-023-03348-7.
3
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions.

本文引用的文献

1
N-Terminal Acetylation Preserves α-Synuclein from Oligomerization by Blocking Intermolecular Hydrogen Bonds.N-端乙酰化通过阻止分子间氢键来防止α-突触核蛋白寡聚化。
ACS Chem Neurosci. 2017 Oct 18;8(10):2145-2151. doi: 10.1021/acschemneuro.7b00250. Epub 2017 Jul 27.
2
SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson's disease.沉默调节蛋白1可改善氧化应激诱导的神经细胞死亡,且在帕金森病中表达下调。
BMC Neurosci. 2017 Jun 2;18(1):46. doi: 10.1186/s12868-017-0364-1.
3
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.
外周组织中的α-突触核蛋白作为神经疾病和其他医学病症的可能标志物。
Biomolecules. 2023 Aug 18;13(8):1263. doi: 10.3390/biom13081263.
4
SIRT2 plays complex roles in neuroinflammation neuroimmunology-associated disorders.SIRT2 在神经炎症-神经免疫相关疾病中发挥复杂作用。
Front Immunol. 2023 May 5;14:1174180. doi: 10.3389/fimmu.2023.1174180. eCollection 2023.
5
Proteomic profiling reveals the potential mechanisms and regulatory targets of sirtuin 4 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's mouse model.蛋白质组学分析揭示了沉默调节蛋白4在1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病小鼠模型中的潜在机制和调控靶点。
Front Neurosci. 2023 Jan 25;16:1035444. doi: 10.3389/fnins.2022.1035444. eCollection 2022.
6
Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.SIRT2 通过细胞外蛋白去乙酰化促进肺癌转移。
Adv Sci (Weinh). 2023 Jan;10(3):e2205462. doi: 10.1002/advs.202205462. Epub 2022 Dec 1.
7
Histone Deacetylases as Epigenetic Targets for Treating Parkinson's Disease.组蛋白去乙酰化酶作为治疗帕金森病的表观遗传学靶点
Brain Sci. 2022 May 21;12(5):672. doi: 10.3390/brainsci12050672.
8
Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson's disease.SIRT1 和 SIRT6 的基因变异和表达变化与帕金森病有关。
Sci Rep. 2021 May 21;11(1):10677. doi: 10.1038/s41598-021-90059-z.
9
Reduced serum SIRT1 levels in patients with Parkinson's disease: a cross-sectional study in China.帕金森病患者血清SIRT1水平降低:一项中国的横断面研究
Neurol Sci. 2021 May;42(5):1835-1841. doi: 10.1007/s10072-020-04711-z. Epub 2020 Sep 9.
10
Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson's disease.针对帕金森病的 SIRT2 抑制剂的设计与体外分析。
Mol Divers. 2021 Nov;25(4):2261-2270. doi: 10.1007/s11030-020-10116-z. Epub 2020 Jun 26.
在帕金森病模型中,沉默调节蛋白2介导α-突触核蛋白毒性加剧的机制。
PLoS Biol. 2017 Mar 3;15(3):e2000374. doi: 10.1371/journal.pbio.2000374. eCollection 2017 Mar.
4
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.基于血液的神经丝轻链蛋白:一种用于帕金森氏症鉴别诊断的生物标志物。
Neurology. 2017 Mar 7;88(10):930-937. doi: 10.1212/WNL.0000000000003680. Epub 2017 Feb 8.
5
Epidemiology of Parkinson's disease.帕金森病的流行病学
J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1.
6
Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.帕金森病临床诊断的准确性:一项系统评价和荟萃分析。
Neurology. 2016 Feb 9;86(6):566-76. doi: 10.1212/WNL.0000000000002350. Epub 2016 Jan 13.
7
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology.阿尔茨海默病病理学的血液蛋白质组学生物标志物
Front Neurol. 2015 Nov 16;6:236. doi: 10.3389/fneur.2015.00236. eCollection 2015.
8
Serological Analysis of Alpha-synuclein and NF-κB in Parkinson's Disease Patients.帕金森病患者中α-突触核蛋白和核因子κB的血清学分析
J Clin Diagn Res. 2015 May;9(5):BC01-4. doi: 10.7860/JCDR/2015/12545.5978. Epub 2015 May 1.
9
Surface plasmon resonance: a versatile technique for biosensor applications.表面等离子体共振:一种用于生物传感器应用的通用技术。
Sensors (Basel). 2015 May 5;15(5):10481-510. doi: 10.3390/s150510481.
10
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.沉默调节蛋白2抑制剂AK7在帕金森病模型中具有神经保护作用,但在肌萎缩侧索硬化症和脑缺血模型中则不然。
PLoS One. 2015 Jan 21;10(1):e0116919. doi: 10.1371/journal.pone.0116919. eCollection 2015.